Summary
Overview
Work History
Education
Skills
Scientific Publications
PATENTS
Languages
ATTENDED INTERNATIONAL AND DOMESTIC CONFERENCES
IT SKILLS
Timeline
Generic

Eriko Padron-Regalado

Atlanta,GA

Summary

Highly skilled and talented researcher, currently a research fellow in the Centers of Disease Control and Prevention (CDC) of the U.S.A. Biotechnology engineer with a M.Sc. degree and a Ph.D. in the study of viruses and vaccines for global infectious diseases from worldwide renowned institutions. 3 years of industry and government experience post-Ph.D. in biologics and vaccine research. Highly-motivated professional with desire to take on new challenges. Strong work ethics and adaptability. Adept at working effectively unsupervised and quickly mastering new skills.

Overview

13
13
years of professional experience

Work History

Review Editor of the Journal Frontiers-Virology

Frontiers Media S.A.
Lausanne, Switzerland
07.2023 - Current
  • Providing an expert review of scientific articles in a rigorous, constructive and efficient manner.

Research Fellow

Centers of Disease Control and Prevention (CDC)
Atlanta, GA
11.2022 - Current
  • Successfully implemented a multiplex immunoassay for national and international surveillance and vaccine evaluation of viral-vaccine preventable diseases
  • Assessed viral vaccine T-cell epitopes using Bioinformatics tools
  • Fellowship by the Oak Ridge Institute of Science and Education (ORISE), an asset of the U.S. Department of Energy

Achievements: named "Best team player" at the division level. Published peer-reviewed scientific articles in highly recognized journals in the field. I was selected by ORISE to share my research and biography in the ORISE website due to the quality of my research and my successful career path.

Senior Researcher in the R&D Department

Landsteiner Scientific S.A.
Toluca, Mexico
08.2020 - 10.2022
  • Technical and scientific evaluation of biologics, small molecules and vaccines for viral diseases, including COVID-19
  • Close communication with national and international stakeholders for product authorization
  • Collaboration with the internal medical department, CROs and KOLs
  • Knowledge of regional and international standards
  • Writing of SOPs

Achievements: collaborated in the approval of COVID-19 vaccines and diagnostics in the country during the pandemic, therefore, protecting the population against this disease.

Independent Consultant/Vaccine Freelancer

Self-employed
Victoria, Mexico
02.2020 - 08.2020
  • Managed an international project related to the development of a new vaccine technology (budget of 97,000 USD)
  • Published a scientific review summarizing the history of coronavirus vaccines (review has been cited more than 190 times and has been downloaded more than 30,000 times worldwide)
  • Participated in international and national scientific talks regarding vaccine development in radio and social media platforms

Researcher (intern)

University of Oxford
Oxford, U.K.
06.2014 - 08.2014
  • Conducted experiments for the production of a new virus-like particle (VLP) vaccine
  • Managed techniques such as molecular cloning, bacterial protein expression, VLP extraction and purification
  • Responsible for maintaining detailed records of experiments and their results and prepare the information resulting from these experiments for presentations at laboratory-wide meetings.

University Lecturer

La Salle University
Victoria, Mexico
08.2011 - 02.2012
  • Taught the subjects of Biochemistry, Cell Biology and Mathematics.

Education

Ph.D. - Clinical Medicine

University of Oxford
Oxford, U.K.
02.2020

Master of Science - Bioscience

KAUST
Saudi Arabia
06.2014

Bachelor of Science - Biotechnology Engineering

ITESM Monterrey
Monterrey, Mexico
12.2010

Skills

  • Experimental Design
  • Research Protocols
  • Qualitative and Quantitative Analysis
  • Proficient in immunoassays, molecular biology techniques, multiplex immunoassays, in-vitro assays, mouse experimentation
  • Interpretation of Findings
  • Analytical Thinking
  • Charting and Graphing
  • Paper Proofreading
  • Self-Driven and Motivated
  • Science communication

Scientific Publications

  • Padron-Regalado, E., Mejía-Olvera, E.E., Marruffo-Carmona, A.M., Solís-Suárez, J.C., Peralta-Agapito, D. and Medina-Rivero, E. (2023), Efficient enzymatic hydrolysis for enriching the antioxidants content of agro-food industrial residues. JSFA Reports. https://doi.org/10.1002/jsf2.145
  • Padron-Regalado E, Ulaszewska M, Douglas AD, Hill AVS, Spencer AJ. STING- pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines. Sci Rep. 2022 Aug 24;12(1):14464. doi: 10.1038/s41598-022-18750-3.
  • Padron-Regalado E, Medina-Rivero E. Perspectives for licensing vaccines in Mexico. Vaccine. 2022 Aug 12;40(34):4979-4985. doi: 10.1016/j.vaccine.2022.07.003. Epub 2022 Jul 11.
  • Padron-Regalado E. Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains. Infect Dis Ther. 2020 Jun;9(2):255-274. doi: 10.1007/s40121-020-00300-x. Epub 2020 Apr 23. Erratum in: Infect Dis Ther. 2021 Mar;10(1):631.
  • Abd El Ghany M, Alsomali M, Almasri M, Padron Regalado E, Naeem R, Tukestani A, Asiri A, Hill-Cawthorne GA, Pain A, Memish ZA. Enteric Infections Circulating during Hajj Seasons, 2011-2013. Emerg Infect Dis. 2017 Oct;23(10):1640–9. doi: 10.3201/eid2310.161642.
  • Alharbi NK, et al. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine. 2017 Jun 27;35(30):3780-3788. doi: 10.1016/j.vaccine.2017.05.032. Epub 2017 Jun 1.
  • Woo YH, et al. Chromerid genomes reveal the evolutionary path from photosynthetic algae to obligate intracellular parasites. Elife. 2015 Jul 15;4:e06974. doi: 10.7554/eLife.06974.

Conference presentations: 

Padron-Regalado, E. et al. (2024). Performance characteristics of a multiplex bead-based assay for the detection of mumps IgG antibodies. Immunology2024 conference organized by the American Association of Immunologists; May 2024; Chicago, IL. The conference discussed the implementation of a high-throughput assay for the detection and titration of anti-mumps virus antibodies in the U.S.A. population.

PATENTS

  

  • Gilbert, Sarah; Hill, V.S. Adrian; Morris, Susan; Padron-Regalado, Eriko (collaborator). 2018. Compositions and methods for inducing an immune response. PCT WO2018215766A1, filed May 23, 2018. Patent pending.
  • Medina-Rivero, Emilio, Padron-Regalado, Eriko. 2023. Process for obtaining substrates with therapeutic activity from the genus Pleurotus and related compositions. PCT/MX2023/050050, filed August 1, 2023. Patent pending.

Languages

Spanish
Native/ Bilingual
English
Native/ Bilingual

ATTENDED INTERNATIONAL AND DOMESTIC CONFERENCES

  • Immunology2024™ conference by the American Association of Immunologists-Chicago 2024
  • First meeting of the International Veterinary Vaccinology Network-Kenya 2018
  • First international symposium of emerging infectious diseases- Mexico 2018

IT SKILLS

  • Proficient in the use of reference management tools (Endnote, Reference Manager Zotero)
  • Proficient in the use of IT office tools (Microsoft Office) and video-conferencing platforms (Teams and Zoom)

Timeline

Review Editor of the Journal Frontiers-Virology

Frontiers Media S.A.
07.2023 - Current

Research Fellow

Centers of Disease Control and Prevention (CDC)
11.2022 - Current

Senior Researcher in the R&D Department

Landsteiner Scientific S.A.
08.2020 - 10.2022

Independent Consultant/Vaccine Freelancer

Self-employed
02.2020 - 08.2020

Researcher (intern)

University of Oxford
06.2014 - 08.2014

University Lecturer

La Salle University
08.2011 - 02.2012

Ph.D. - Clinical Medicine

University of Oxford

Master of Science - Bioscience

KAUST

Bachelor of Science - Biotechnology Engineering

ITESM Monterrey
Eriko Padron-Regalado